Efficacy of novel albendazole salt formulations against secondary cystic echinococcosis in experimentally infected mice
dc.authorid | 0000-0001-9183-7591 | |
dc.authorid | 0000-0001-9183-7591 | |
dc.authorid | 0000-0002-8698-9440 | |
dc.authorid | 0000-0003-2672-5766 | |
dc.authorid | 0000-0002-0622-2128 | |
dc.authorid | 0000-0002-5947-4118 | |
dc.authorscopusid | 23971786000 | |
dc.authorscopusid | 57218705593 | |
dc.authorscopusid | 57190291855 | |
dc.authorscopusid | 57218705880 | |
dc.authorscopusid | 12545052400 | |
dc.authorscopusid | 57212700878 | |
dc.authorscopusid | 12781515600 | |
dc.authorwosid | HAREM, Ismail Sah/ABG-8821-2020 | |
dc.authorwosid | Casulli, Adriano/AAQ-6859-2020 | |
dc.authorwosid | Carradori, Simone/S-4776-2019 | |
dc.authorwosid | CASULLI, ADRIANO/O-2278-2015 | |
dc.authorwosid | Lundstrom-Stadelmann, Britta/E-8042-2011 | |
dc.contributor.author | Vural, G. | |
dc.contributor.author | Yardımcı, Mehmet | |
dc.contributor.author | Koçak, Melek | |
dc.contributor.author | Yaşar, Tuba Özge | |
dc.contributor.author | Kurt, A. | |
dc.contributor.author | Harem, İsmail Şah | |
dc.contributor.author | Casulli, Adriano | |
dc.date.accessioned | 2022-05-11T14:42:29Z | |
dc.date.available | 2022-05-11T14:42:29Z | |
dc.date.issued | 2020 | |
dc.department | Fakülteler, Veteriner Fakültesi, Temel Bilimler Bölümü, Histoloji ve Embriyoloji Ana Bilim Dalı | |
dc.description.abstract | In this study, we evaluated the efficacy, expressed as a mean weight decrease of the whole echinococcal cyst mass, of novel benzimidazole salt formulations in a murine Echinococcus granulosus infection model. BALB/c mice were intraperitoneally infected with protoscoleces of E. granulosus (genotype G1). At 9 months post-infection, treatment with albendazole (ABZ), ricobendazole (RBZ) salt formulations, and RBZ enantiomer salts (R)-(+)-RBZ-Na and (S)-(-)-RBZ-Na formulations were initiated. Drugs were orally applied by gavage at 10 mg kg(-1) body weight per day during 30 days. Experimental treatments with benzimidazole sodium salts resulted in a significant reduction of the weight of cysts compared to conventional ABZ treatment, except for the (S)-(-)-RBZ-Na enantiomer formulation. Scanning electron microscopy and histological inspection revealed that treatments impacted not only the structural integrity of the parasite tissue in the germinal layer, but also induced alterations in the laminated layer. Overall, these results demonstrate the improved efficacy of benzimidazole salt formulations compared to conventional ABZ treatment in experimental murine cystic echinococcosis. | |
dc.description.sponsorship | European UnionEuropean Commission [602051] | |
dc.description.sponsorship | The research leading to these results received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under the project HERACLES (http://www.heracles-fp7.eu/), grant agreement no. 602051. The funder of the study had no role in study design, data collection, data analysis, data interpretation or writing of the report. | |
dc.identifier.doi | 10.1017/S0031182020001225 | |
dc.identifier.endpage | 1432 | |
dc.identifier.issn | 0031-1820 | |
dc.identifier.issn | 1469-8161 | |
dc.identifier.issue | 13 | en_US |
dc.identifier.pmid | 32729453 | |
dc.identifier.scopus | 2-s2.0-85090156361 | |
dc.identifier.scopusquality | Q1 | |
dc.identifier.startpage | 1425 | |
dc.identifier.uri | https://doi.org/10.1017/S0031182020001225 | |
dc.identifier.uri | https://hdl.handle.net/20.500.11776/9390 | |
dc.identifier.volume | 147 | |
dc.identifier.wos | WOS:000590482000006 | |
dc.identifier.wosquality | Q2 | |
dc.indekslendigikaynak | Web of Science | |
dc.indekslendigikaynak | Scopus | |
dc.indekslendigikaynak | PubMed | |
dc.institutionauthor | Koçak, Melek | |
dc.institutionauthor | Yardımcı, Mehmet | |
dc.institutionauthor | Yaşar, T. O. | |
dc.language.iso | en | |
dc.publisher | Cambridge Univ Press | |
dc.relation.ispartof | Parasitology | |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | |
dc.subject | Albendazole | |
dc.subject | Echinococcus granulosus | |
dc.subject | efficacy | |
dc.subject | enantiomers | |
dc.subject | mouse model | |
dc.subject | new formulations | |
dc.subject | ricobendazole | |
dc.subject | salts of benzimidazoles | |
dc.subject | salts of ricobendazole | |
dc.subject | secondary cystic echinococcosis | |
dc.subject | Sulfoxide Enantiomers | |
dc.subject | In-Vitro | |
dc.subject | Granulosus | |
dc.subject | Flubendazole | |
dc.subject | Nitazoxanide | |
dc.subject | Burden | |
dc.title | Efficacy of novel albendazole salt formulations against secondary cystic echinococcosis in experimentally infected mice | |
dc.type | Article |
Dosyalar
Orijinal paket
1 - 1 / 1
Küçük Resim Yok
- İsim:
- 9390-2.pdf
- Boyut:
- 795.52 KB
- Biçim:
- Adobe Portable Document Format
- Açıklama:
- Tam Metin / Full Text